Last updated: March 18, 2024
Sponsor: University Hospital, Grenoble
Overall Status: Active - Recruiting
Phase
N/A
Condition
Epilepsy
Epilepsy (Pediatric)
Treatment
SEEG Group
Clinical Study ID
NCT03644732
38RC17.357
2017-A03248-45
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Drug-resistant focal epilepsy
- Justified SEEG exploration in the context of presurgical assessment of epilepsy
- Written non-opposition to study participation
- Intellectual capacities compatible with the compliance in the cognitive tasks
Exclusion
Exclusion Criteria:
- Major Patient undergoing a legal protection measure or patient deprived of liberty asa result of a judicial or administrative decision
- Impossibility of collecting information on exposure (recent arrival in France, foreignlanguage, etc.)
- Pregnant women (Contraindication to SEEG exploration)
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: SEEG Group
Phase:
Study Start date:
April 05, 2018
Estimated Completion Date:
September 30, 2030
Study Description
Connect with a study center
University Hospital, Grenoble
Grenoble, 38043
FranceActive - Recruiting
CHRU Nancy
Nancy,
FranceActive - Recruiting
Hôpital Ste Anne
Paris, 75014
FranceActive - Recruiting
CHU Rennes
Rennes,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.